Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1922 1
1932 1
1934 1
1946 3
1947 3
1948 10
1949 10
1950 5
1951 3
1952 4
1953 5
1954 4
1955 4
1956 7
1957 6
1958 3
1959 6
1960 9
1961 8
1962 8
1963 9
1964 10
1965 20
1966 16
1967 10
1968 9
1969 12
1970 11
1971 13
1972 13
1973 15
1974 16
1975 23
1976 21
1977 16
1978 26
1979 30
1980 31
1981 42
1982 54
1983 51
1984 58
1985 59
1986 50
1987 66
1988 51
1989 48
1990 57
1991 75
1992 77
1993 70
1994 72
1995 77
1996 72
1997 69
1998 55
1999 57
2000 75
2001 59
2002 79
2003 82
2004 77
2005 75
2006 71
2007 80
2008 77
2009 85
2010 98
2011 88
2012 81
2013 83
2014 85
2015 71
2016 66
2017 75
2018 60
2019 58
2020 111
2021 106
2022 104
2023 90
2024 78
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,394 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology and Pathophysiology of Multiple Sclerosis.
Ward M, Goldman MD. Ward M, et al. Among authors: goldman md. Continuum (Minneap Minn). 2022 Aug 1;28(4):988-1005. doi: 10.1212/CON.0000000000001136. Continuum (Minneap Minn). 2022. PMID: 35938654 Review.
Primary polydipsia: Update.
Ahmadi L, Goldman MB. Ahmadi L, et al. Among authors: goldman mb. Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101469. doi: 10.1016/j.beem.2020.101469. Epub 2020 Oct 14. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 33222764 Free PMC article. Review.
Medical therapies for melasma.
Mahajan VK, Patil A, Blicharz L, Kassir M, Konnikov N, Gold MH, Goldman MP, Galadari H, Goldust M. Mahajan VK, et al. Among authors: goldman mp. J Cosmet Dermatol. 2022 Sep;21(9):3707-3728. doi: 10.1111/jocd.15242. Epub 2022 Jul 31. J Cosmet Dermatol. 2022. PMID: 35854432 Review.
Benralizumab for the Prevention of COPD Exacerbations.
Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators. Criner GJ, et al. Among authors: goldman m. N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112385 Clinical Trial.
International collaboration.
Goldman MP, Murrell DF, Al-Mutairi N, Arenbergerova M, Dréno B, Alhaddad M, Al-Suwaidan SN, Firooz A, van de Kerkhof PCM, Feldman SR. Goldman MP, et al. J Dermatolog Treat. 2020 Dec;31(8):757. doi: 10.1080/09546634.2020.1794290. J Dermatolog Treat. 2020. PMID: 32646257 Free article. No abstract available.
Schizophrenia.
Goldman ML, Pincus HA, Mangurian C. Goldman ML, et al. N Engl J Med. 2020 Feb 6;382(6):583-584. doi: 10.1056/NEJMc1915943. N Engl J Med. 2020. PMID: 32023392 No abstract available.
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, Goldman M; SIROCCO study investigators. Bleecker ER, et al. Among authors: goldman m. Lancet. 2016 Oct 29;388(10056):2115-2127. doi: 10.1016/S0140-6736(16)31324-1. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609408 Clinical Trial.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators. FitzGerald JM, et al. Among authors: goldman m. Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609406 Clinical Trial.
Editorial: Research reproducibility and preventing fraud.
Uchida S, Yu J, Goldman M, Asmis R, Yang X, Aikawa E, Bourantas C, Aikawa M, Tevaearai Stahel H. Uchida S, et al. Among authors: goldman m. Front Cardiovasc Med. 2022 Aug 1;9:979467. doi: 10.3389/fcvm.2022.979467. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35979020 Free PMC article. No abstract available.
3,394 results